# Bacopa Memory Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/bacopa-memory-randomized-trial-evidence-review
Category: evidence-review
Summary: Bacopa Memory Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomiz
Last reviewed: 2026-06-10
Reviewed by: Migaku Evidence Review
# Bacopa Memory Randomized Trial: What the Evidence Says

## Quick Answer

Bacopa Memory Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial | randomized trial | 2 | 2026-01-01 | 10.2196/82891 |
| Phytochemical and Fungal Bioactive Compounds in the “Brain Health Triad”: A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy | preclinical study | 4 | 2026-04-18 | 10.3390/ijms27083607 |

## What The Sources Report

- There was heterogeneity in dosage, duration, formulation, follow-up, and outcomes, and the overall quality of evidence was very low due to high risk of bias, small sample size, and wide CIs. [Dwivedi Abhilasha (2026); evidence level 2]
- Under normal conditions, it is sequestered in the cytoplasm by Kelch-like ECH-associated protein 1 (Keap1), which targets it for degradation. [Cipriano Giovanni Luca (2026); evidence level 4]
- The following subsections provide a detailed analysis of the molecular profiles and clinical evidence for these three primary bioactives. [Cipriano Giovanni Luca (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For bacopa memory randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dwivedi Abhilasha (2026). Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial. DOI: 10.2196/82891. PMCID: PMC12935425. PMID: 41740144. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935425/
- Cipriano Giovanni Luca (2026). Phytochemical and Fungal Bioactive Compounds in the “Brain Health Triad”: A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. DOI: 10.3390/ijms27083607. PMCID: PMC13116414. PMID: 42074246. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13116414/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.